Pew Research Center conducted this study to understand Americans’ views of the coronavirus and COVID-19 vaccines. For this analysis, we surveyed 10,133 U.S. adults from Feb. 7 to 11, 2024. Everyone ...

Amid the declining clinical severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and diminishing public uptake of annual coronavirus disease 2019 (Covid-19) vaccines, ...

Five years ago, strict measures were introduced in Germany to contain the spread of COVID-19. Almost all stores, businesses, and schools were closed. Today, Germany is still divided over how the ...

COVID-19 viral activity was high in the United States during the first week of September, according to fresh data from the Centers for Disease Control and Prevention. Some regions of the United States ...

Kim Parker contributed to this chapter. The COVID-19 pandemic sent shockwaves through the U.S. labor market. Businesses shuttered, millions of Americans lost their jobs, and for many others their home ...

Nirmatrelvir in combination with ritonavir is an antiviral treatment for mild-to-moderate coronavirus disease 2019 (Covid-19). The efficacy of this treatment in patients who are at standard risk for ...